US2018251452A1PendingUtilityA1

Crystalline pharmaceutical and methods of preparation and use thereof

66
Assignee: SARCODE BIOSCIENCE INCPriority: Oct 21, 2009Filed: Jan 29, 2018Published: Sep 6, 2018
Est. expiryOct 21, 2029(~3.3 yrs left)· nominal 20-yr term from priority
Inventors:John Burnier
C07D 405/06C07D 405/10
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.

Claims

exact text as granted — not AI-modified
1 .- 14 . (canceled) 
     
     
         15 . An isolated compound of Formula I:

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.